Israel Englander Vaxcyte, Inc. Transaction History

Millennium Management LLC

$175 Billion
Q1 2025

A detailed history of Israel Englander (Millennium Management LLC) transactions in Vaxcyte, Inc. stock. As of the latest transaction made, Millennium Management LLC holds 30,000 shares of PCVX stock, worth $1.04 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

30,000

Previous 276,578 89.15%

Holding current value

$1.04 Million

Previous $22.6 Million 95.0%

% of portfolio

0.0%

Previous 0.01%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	BUY	$37.76 - $92.13 $5.17 Million - $12.6 Million	136,851 Added 49.48%	413,429 $15.6 Million
Q4 2024 Feb 14, 2025	SELL	$80.97 - $117.93 $1.77 Million - $2.58 Million	-21,857 Reduced 7.32%	276,578 $22.6 Million
Q3 2024 Nov 14, 2024	BUY	$70.52 - $117.12 $6.68 Million - $11.1 Million	94,704 Added 46.48%	298,435 $34.1 Million
Q2 2024 Aug 14, 2024	SELL	$60.06 - $78.77 $195,255 - $256,081	-3,251 Reduced 1.57%	203,731 $15.4 Million
Q1 2024 May 15, 2024	SELL	$59.79 - $81.05 $29 Million - $39.3 Million	-484,450 Reduced 70.06%	206,982 $14.1 Million
Q4 2023 Feb 14, 2024	SELL	$45.35 - $63.41 $23.7 Million - $33.1 Million	-522,640 Reduced 43.05%	691,432 $43.4 Million
Q2 2023 Aug 14, 2023	SELL	$34.66 - $54.07 $3.45 Million - $5.38 Million	-99,570 Reduced 7.58%	1,214,072 $60.6 Million
Q1 2023 May 15, 2023	BUY	$36.27 - $47.2 $3.41 Million - $4.44 Million	94,151 Added 7.72%	1,313,642 $49.2 Million
Q4 2022 Feb 14, 2023	BUY	$20.58 - $47.95 $8.91 Million - $20.8 Million	433,169 Added 55.09%	1,219,491 $58.5 Million
Q3 2022 Nov 14, 2022	BUY	$21.69 - $28.53 $4.78 Million - $6.28 Million	220,206 Added 38.9%	786,322 $18.9 Million
Q2 2022 Aug 15, 2022	BUY	$17.68 - $26.58 $5.36 Million - $8.06 Million	303,396 Added 115.48%	566,116 $12.3 Million
Q1 2022 May 16, 2022	SELL	$17.46 - $26.36 $412,108 - $622,175	-23,603 Reduced 8.24%	262,720 $6.35 Million
Q4 2021 Feb 14, 2022	BUY	$19.32 - $26.45 $97,353 - $133,281	5,039 Added 1.79%	286,323 $6.81 Million
Q3 2021 Nov 15, 2021	SELL	$20.26 - $26.97 $695,505 - $925,853	-34,329 Reduced 10.88%	281,284 $7.14 Million
Q2 2021 Aug 16, 2021	SELL	$16.45 - $24.06 $622,484 - $910,454	-37,841 Reduced 10.71%	315,613 $7.1 Million
Q1 2021 May 17, 2021	SELL	$18.66 - $29.16 $1.35 Million - $2.11 Million	-72,370 Reduced 17.0%	353,454 $6.98 Million
Q4 2020 Feb 16, 2021	BUY	$26.57 - $51.74 $8.77 Million - $17.1 Million	330,164 Added 345.14%	425,824 $11.3 Million
Q3 2020 Nov 16, 2020	SELL	$26.5 - $55.4 $20.5 Million - $42.8 Million	-772,658 Reduced 88.98%	95,660 $4.72 Million
Q2 2020 Aug 14, 2020	BUY	$26.15 - $35.45 $22.7 Million - $30.8 Million	868,318 New	868,318 $27.4 Million

Others Institutions Holding PCVX

# of Institutions

345

Shares Held

136M

Call Options Held

348K

Put Options Held

250K

View Full List

About Vaxcyte, Inc.

Ticker PCVX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,315,100
Market Cap $2.06B
Description
Vaxcyte, Inc., a clinical-stage biotechnology vaccine company, develops novel protein vaccines to prevent or treat bacterial infectious diseases. Its lead vaccine candidate is VAX-24, a 24-valent investigational pneumococcal conjugate vaccine that is in Phase 1/2 clinical trials to treat invasive pneumococcal disease and pneumonia. The company a...

More about PCVX

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account